HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A corrigendum has been published All Versions of this Article: 287/1/R181    most recent 00555.2002v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Rajapakse, N. W. Articles by Evans, R. G. Search for Related Content PubMed PubMed Citation Articles by Rajapakse, N. W. Articles by Evans, R. G.

LOCAL CONTROL OF CIRCULATION

Modulation of V₁-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids

¹Department of Physiology, Monash University, Victoria 3800, Australia; and ²Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226; and ³Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Centre, Dallas, Texas 75235

Submitted 9 September 2002 ; accepted in final form 24 February 2004

This study examined the effects of renal arterial infusion of a selective cytochrome P-450 epoxygenase inhibitor, N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide (MS-PPOH; 2 mg/kg plus 1.5 mg·kg^–1·h^–1), on renal hemodynamic responses to infusions of [Phe²,Ile³,Orn⁸]vasopressin and ANG II into the renal artery of anesthetized rabbits. MS-PPOH did not affect basal renal blood flow (RBF) or cortical or medullary blood flow measured by laser-Doppler flowmetry (CLDF/MLDF). In vehicle-treated rabbits, [Phe²,Ile³,Orn⁸]vasopressin (30 ng·kg^–1·min^–1) reduced MLDF by 62 ± 7% but CLDF and RBF were unaltered. In MS-PPOH-treated rabbits, RBF and CLDF fell by 51 ± 8 and 59 ± 13%, respectively, when [Phe²,Ile³,Orn⁸]vasopressin was infused. MS-PPOH had no significant effects on the MLDF response to [Phe²,Ile³,Orn⁸]vasopressin (43 ± 9% reduction). ANG II (20 ng·kg^–1·min^–1) reduced RBF by 45 ± 10% and CLDF by 41 ± 14%, but MLDF was not significantly altered. MS-PPOH did not affect blood flow responses to ANG II. Formation of epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids (DiHETEs) was 49% lower in homogenates prepared from the renal cortex of MS-PPOH-treated rabbits than from vehicle-treated rabbits. MS-PPOH had no effect on the renal formation of 20-hydroxyeicosatetraenoic acid (20-HETE). Incubation of renal cortical homogenates from untreated rabbits with [Phe²,Ile³,Orn⁸]vasopressin (0.2–20 ng/ml) did not affect formation of EETs, DiHETEs, or 20-HETE. These results do not support a role for de novo EET synthesis in modulating renal hemodynamic responses to ANG II. However, EETs appear to selectively oppose V₁-receptor-mediated vasoconstriction in the renal cortex but not in the medullary circulation and contribute to the relative insensitivity of medullary blood flow to V₁-receptor activation.

angiotensin II; cytochrome P-450 enzyme system; kidney cortex; kidney medulla; renal circulation; vasopressin

This article has been cited by other articles:

				S. M. Fitzgerald, H. Bashari, J. A. Cox, H. C. Parkington, and R. G. Evans Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1072 - H1082. [Abstract] [Full Text] [PDF]